Abstract:Background & aims: Resection is the most widely used potentially curative treatment for patients with early hepatocellular carcinoma (HCC). However, recurrence within 2 years occurs in 30-50% of patients, being the major cause of mortality. Herein, we describe 2 models, both based on widely available clinical data, which permit risk of early recurrence to be assessed before and after resection. Methods: A total of 3,903 patients undergoing surgical resection with curative intent were recruited from 6 different centres. We built 2 models for early recurrence, 1 using preoperative and 1 using pre and post-operative data, which were internally validated in the Hong Kong cohort. The models were then externally validated in European, Chinese and US cohorts. We developed 2 online calculators to permit easy clinical application. Results: Multivariable analysis identified male gender, large tumour size, multinodular tumour, high albumin-bilirubin (ALBI) grade and high serum alpha-fetoprotein as the key parameters related to early recurrence. Using these variables, a preoperative model (ERASL-pre) gave 3 risk strata for recurrence-free survival (RFS) in the entire cohort - low risk: 2-year RFS 64.8%, intermediate risk: 2-year RFS 42.5% and high risk: 2-year RFS 20.7%. Median survival in each stratum was similar between centres and the discrimination between the 3 strata was enhanced in the post-operative model (ERASL-post) which included 'microvascular invasion'. Conclusions: Statistical models that can predict the risk of early HCC recurrence after resection have been developed, extensively validated and shown to be applicable in the international setting. Such models will be valuable in guiding surveillance follow-up and in the design of post-resection adjuvant therapy trials. Lay summary: The most effective treatment of hepatocellular carcinoma is surgical removal of the tumour but there is often recurrence. In this large international study, we develop a statistical method that allows clinicians to estimate the risk of recurrence in an individual patient. This facility enhances communication with the patient about the likely success of the treatment and will help in designing clinical trials that aim to find drugs that decrease the risk of recurrence.

Smoking as a Risk Factor for Very Late Recurrence in Surgically Resected Early-Stage Primary Hepatocellular Carcinoma

Early Versus Late Recurrence of Hepatocellular Carcinoma After Surgical Resection Based on Post-recurrence Survival: an International Multi-institutional Analysis

Analysis of factors influencing recurrence of hepatocellular carcinoma patients after hepatectomy

Clinical Features of Recurrence After Hepatic Resection for Early-Stage Hepatocellular Carcinoma and Long-Term Survival Outcomes of Patients with Recurrence: A Multi-institutional Analysis

Recurrence Pattern Is an Independent Surgical Prognostic Factor for Long-Term Oncological Outcomes in Patients with Hepatocellular Carcinoma

Different risk factors and therapy for early and late recurrence after resection of hepatocellular carcinoma

Recurrence after Resection of Alpha-Fetoprotein-Positive Hepatocellular-Carcinoma

Recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors

Early Recurrence in Large Hepatocellular Carcinoma after Curative Hepatic Resection: Prognostic Significance and Risk Factors.

Preoperative Inflammation-Based Markers Pre- Dict Early and Late Recurrence of Hepatocellular Carcinoma after Curative Hepatectomy

Specific risk factors contributing to early and late recurrences of intrahepatic cholangiocarcinoma after curative resection

Long-term survival and recurrence after curative resection for hepatocellular carcinoma in patients with chronic hepatitis C virus infection: a multicenter observational study from China

Risk Factors for Recurrence of Small Hepatocellular Carcinoma after Long-Term Follow-Up of Percutaneous Radiofrequency Ablation

Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection

Risk factors for recurrence in patients with hepato-cellular carcinoma after radical resection

Risk factors for early postoperative recurrence in single and small hepatitis B virus-associated primary hepatocellular carcinoma

Risk Factors of Recurrence and Poor Survival in Curatively Resected Hepatocellular Carcinoma with Microvascular Invasion

Development and Validation of a Machine Learning Prognostic Model for Hepatocellular Carcinoma Recurrence After Surgical Resection

Multivariate Analysis of Risk Factors of Early and Late Recurrences after Resection for Primary Clear Cell Carcinoma of Liver

High Hepatitis B Viral Load Predicts Recurrence of Small Hepatocellular Carcinoma after Curative Resection

Clinical Characteristics, Outcome, and Risk Factors for Early and Late Intrahepatic Recurrence of Female Patients after Curative Resection of Hepatocellular Carcinoma.